Pulse Corp (PLSE): Price Target Chart

Market fluctuations in Pulse Biosciences, Inc. (PLSE) shares on the GURU.Markets platform, where the metric is fixed at 67.52, confirm the stability of its engineering staff and certification specialists. The business relies on alliances with cardiologists to improve the fight against arrhythmia, as well as joint research with medical professionals to advance oncology and cosmetology through pulsed technologies.

Pulse Corp (PLSE): Analyst Consensus Forecast from 07/04/2022 to 11/11/2026

Analytical breakdowns for Pulse Corp (PLSE)

- share price and expert price forecast:

Quote Chart pulsebiosciences.com|PLSE - Price Target Chart

- stock exchange capitalization data:

Market Value Pulse Corp|PLSE - Total Company Value

- issuer book value statistics:

Net Assets per Share Pulse Biosciences|PLSE - Book Capitalization|Market-to-Book Ratio pulsebiosciences.com|PLSE - Cumulative Company Assets

- issuer credit burden and liquidity indicators:

- net income and valuation ratios data:

PLSE - Company Net Income|Forward Earnings Pulse Biosciences, Inc.|PLSE - P/E Multiple|Projected Price to Earnings Ratio Pulse Biosciences Inc|PLSE - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Pulse Corp|PLSE - Operating profit before deduction of amortization|Earnings per share for the last four quarters Pulse Biosciences|PLSE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months pulsebiosciences.com|PLSE - Earnings growth in current year|Expected earnings per share growth for next year Pulse Biosciences, Inc.

General company analysis:PLSE - pulsebiosciences.com

Pulse Biosciences, Inc. (PLSE) is currently adapting its internal processes for the launch of new therapeutic systems amid regulatory expectations. The consensus market value forecast for the stock on GURU.Markets allows for the separation of the fundamental revaluation of Pulse Biosciences, Inc. (PLSE) from market noise. This metric is formed as a weighted average of target prices from independent analysts. The indicator measures the aggregate market expectation regarding the asset's fair value. Investors should utilize this data to minimize errors when determining their entry point.

Competitors of Pulse Biosciences, Inc.